Miconazole, a pharmacological barrier to skin fungal infections
暂无分享,去创建一个
[1] G. Piérard,et al. Established and emerging oral antifungals in dermatology , 2013 .
[2] S. Cheng,et al. Development of miconazole nitrate containing chitosan microcapsules and their anti-Aspergillus niger activity , 2012, Journal of microencapsulation.
[3] T. Foster,et al. Miconazole Induces Fungistasis and Increases Killing of Candida albicans Subjected to Photodynamic Therapy † , 2012, Photochemistry and photobiology.
[4] R. Musioł,et al. Azole antimycotics--a highway to new drugs or a dead end? , 2012, Current medicinal chemistry.
[5] M. Kovac,et al. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin , 2012, Journal of clinical pharmacy and therapeutics.
[6] R. N. Brogden,et al. Miconazole: A Review of its Antifungal Activity and Therapeutic Efficacy , 2012, Drugs.
[7] Y. Sawada,et al. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model , 2011, Journal of clinical pharmacy and therapeutics.
[8] J. Perfect,et al. Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations , 2011, Expert opinion on emerging drugs.
[9] Jeannina A Smith,et al. Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability , 2011, Patient preference and adherence.
[10] R. Prasad,et al. The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans , 2011, Antimicrobial Agents and Chemotherapy.
[11] H. Nelis,et al. Superoxide Dismutases Are Involved in Candida albicans Biofilm Persistence against Miconazole , 2011, Antimicrobial Agents and Chemotherapy.
[12] M. Ghannoum,et al. Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance , 2011, Mycoses.
[13] Christine D Wu,et al. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures. , 2011, Archives of oral biology.
[14] Z. Dvořák. Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition. , 2011, Toxicology letters.
[15] R. Bensadoun,et al. Miconazole mucoadhesive tablet for oropharyngeal candidiasis , 2011, Expert review of anti-infective therapy.
[16] A. Franks,et al. Hyperprothrombinemia as a Result of a Possible Warfarin and Intravaginal Miconazole Interaction , 2010, Southern medical journal.
[17] M. Ghannoum,et al. Antifungal activity of miconazole against recent Candida strains , 2010, Mycoses.
[18] M. Mazzotti,et al. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.
[19] E. Puijenbroek,et al. Interaction between topical miconazole and coumarins , 2010, European Journal of Clinical Pharmacology.
[20] N. Musaji. Antifungal drug resistance: not all azoles are equal , 2010, Expert review of anti-infective therapy.
[21] N. Karami,et al. Antimicrobial activity of topical skin pharmaceuticals - an in vitro study. , 2010, Acta dermato-venereologica.
[22] S. Grether-Beck,et al. Involvement of Lipid Rafts and Caveolins in UVA Signaling , 2009 .
[23] Ana Espinel-Ingroff,et al. Antifungal drug resistance mechanisms , 2009, Expert review of anti-infective therapy.
[24] D. Elston. Topical antibiotics in dermatology: emerging patterns of resistance. , 2009, Dermatologic clinics.
[25] G. Piérard,et al. Updating Corneofungimetry: A Bioassay Exploring Dermatomycoses and Antifungal Susceptibility , 2009, Mycopathologia.
[26] J. Arrese,et al. Clinicopathologic presentations of dermatomycoses in cancer patients , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[27] A. Barasch,et al. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. , 2008, Future microbiology.
[28] Aditya K. Gupta,et al. Update in Antifungal Therapy of Dermatophytosis , 2008, Mycopathologia.
[29] B. Zee,et al. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double‐blind, controlled trial using one side of the elbow or knee as a control , 2008, International journal of dermatology.
[30] G. Piérard,et al. Novelties in the multifaceted miconazole effects on skin disorders. , 2008, Expert opinion on pharmacotherapy.
[31] G. Dive,et al. Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: molecular modeling studies. , 2007, International journal of pharmaceutics.
[32] W. Du,et al. Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast* , 2007, Journal of Biological Chemistry.
[33] L. Eichenfield,et al. Absorption and efficacy of miconazole nitrate 0.25% ointment in infants with diaper dermatitis. , 2007, Journal of drugs in dermatology : JDD.
[34] G. Piérard,et al. [How I treat....A stoutness-associated intertrigo]. , 2007, Revue medicale de Liege.
[35] J. Heeres,et al. Antifungal azoles for skin disorders , 2006 .
[36] A. Fothergill. Miconazole: a historical perspective , 2006, Expert review of anti-infective therapy.
[37] J. Quiring,et al. Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis. , 2006, Cutis.
[38] J. Ausma,et al. Azoles: mode of antifungal action and resistance development. Effect of miconazole on endogenous reactive oxygen species production in Candida albicans , 2006 .
[39] E. Warshaw,et al. Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. , 2005, Journal of the American Academy of Dermatology.
[40] G. Piérard,et al. Tribological and mycological consequences of the use of a miconazole nitrate-containing paste for the prevention of diaper dermatitis: an open pilot study , 1996, European Journal of Pediatrics.
[41] J. Ausma,et al. Involvement of lipid rafts in antifungal mode of action of miconazole , 2005 .
[42] K. Nickerson,et al. Defined Anaerobic Growth Medium for Studying Candida albicans Basic Biology and Resistance to Eight Antifungal Drugs , 2004, Antimicrobial Agents and Chemotherapy.
[43] K. Nickerson,et al. Enhanced Production of Farnesol by Candida albicans Treated with Four Azoles , 2004, Antimicrobial Agents and Chemotherapy.
[44] C. Osborne,et al. Antifungal drug response in an in vitro model of dermatophyte nail infection. , 2004, Medical mycology.
[45] J. Arrese,et al. Treatment Failures and Relapses in Onychomycosis: A Stubborn Clinical Problem , 2003, Dermatology.
[46] N. Tsuji,et al. Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect , 2002, Antimicrobial Agents and Chemotherapy.
[47] Steven Phillips,et al. Diaper Dermatitis: A Therapeutic Dilemma. Results of a Double‐Blind Placebo Controlled Trial of Miconazole Nitrate 0.25% , 2001, Pediatric dermatology.
[48] G. Piérard,et al. Biometrological assessment of the preventive effect of a miconazole spray powder on athlete's foot , 1996, Clinical and experimental dermatology.
[49] C. Tur,et al. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus. , 1996, The Journal of antimicrobial chemotherapy.
[50] L. Fernández,et al. Systemic contact dermatitis from miconazole , 1996, Contact dermatitis.
[51] G. Piérard,et al. Comparative study of the activity and lingering effect of topical antifungals. , 1993, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[52] H. Baes. Contact sensitivity to miconazole with ortho‐chloro cross‐sensitivity to other imidazoles , 1991, Contact dermatitis.
[53] R. Happle,et al. Contact allergy to miconazole , 1988, Contact dermatitis.
[54] R. Fromtling. Overview of medically important antifungal azole derivatives , 1988, Clinical Microbiology Reviews.
[55] F. Odds,et al. Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions. , 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[56] M. Borgers,et al. Cytochemical localization of NADH oxidase in Candida albicans. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[57] M. Borgers,et al. An Ultrastructural and Cytochemical Study of Candida aIbicans after in Vitro Treatment with Imidazoles , 1976, Mykosen.
[58] M. Borgers,et al. The ultrastructure of Candida albicans after in vitro treatment with miconazole. , 1974, Sabouraudia.
[59] J. V. van Cutsem,et al. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. , 1972, Chemotherapy.